Phytomolecules Repurposed as Covid-19 Inhibitors: Opportunity and Challenges

The SARS-CoV-2 virus has spread worldwide to cause a full blown pandemic since 2020. To date, several promising synthetic therapeutics are repurposed and vaccines through different stages of clinical trials were approved and being administered, but still the efficacy of the drugs and vaccines are ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandramouli, Vaishnavi, Niraj, Shekhar Kumar, Nair, Krishna G., Joseph, Jerrine, Aruni, Wilson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390070/
https://www.ncbi.nlm.nih.gov/pubmed/34448061
http://dx.doi.org/10.1007/s00284-021-02639-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390070/
https://www.ncbi.nlm.nih.gov/pubmed/34448061
http://dx.doi.org/10.1007/s00284-021-02639-x

Ejemplares similares